Anti-β <sub>2</sub> -Glycoprotein I Antibodies in Sneddon’s Syndrome
C. Françès(Navarre Institute of Health Research), Ayman Tourbah(Centre Hospitalier Universitaire de Reims), J.-P. Viard(Hôpital Necker-Enfants Malades), J.C. Piette(Sorbonne Université)
Cited by 14
Related Papers
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|262
Skin Thickness Changes in Normal Aging Skin
|Gerontology|2009|258
Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients
|Annals of the Rheumatic Diseases|2007|235
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
|Multiple Sclerosis and Related Disorders|2020|179